BioSpace News Archive

Advicenne (Paris:ADVIC), a specialty pharmaceutical company focused on the development of pediatric-friendly therapeutics for the treatment of orphan renal and neurological diseases, announced today that it has received a No Objection Letter to extend its ARENA-2 pivotal Phase III trial

The Independence Fund today launched a new Family program for the children of wounded Veterans and their Caregivers.

The 25th running of the Eversource Hartford Marathon was won in 2:18:23 by David Sinclair of Peru, VT. Rachel Schilkowsky of Providence, RI, won the women’s race in 2:41:03 in her first marathon, qualifying to run in the Olympic Marathon Trials.

Using Global Handwashing Day (October 15) as Platform to Kick Off Program, Free Instruction Kits Now Available to Teachers, School Administrators

Today, two Illinois-based nonprofit risk pools, who provide more than 203 local municipalities and other public entities with cost-effective workers’ compensation and employee healthcare insurance, filed a joint lawsuit in the Circuit Court of Cook County against leading opioid manufacturers, distributors, professional associations, and prescribers.

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it will report third quarter financial results after the Nasdaq market closes on Monday, Nov. 5, 2018.

AcelRx Pharmaceuticals, Inc. today announced a poster presentation at the American Society of Anesthesiologists (ASA) in San Francisco highlighting sublingual sufentanil.

Management Team to Transition to Consulting Roles in Effort to Streamline Operations and Manage Expenses

Senseonics Holdings, Inc. today announced that it plans to release its third quarter 2018 financial results after market close on Thursday, November 8, 2018.

Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its third quarter ended September 30, 2018 after the market closes on Thursday, October 25, 2018.